Catalyst Wire Dossier Catalyst Wire Dossier

BEPREVE 1.5%

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEPREVE 1.5%, covering 2020-03-31 to 2020-03-31. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer [Phase 4]

See pricing